In the past year, shares of Halozyme have rallied 65.8% against the industry’s decline of 3.5%. Several companies use HALO’s Enhanze technology to develop a subcutaneous formulation of their ...
HALO is a #3 (Hold) on the Zacks Rank, with a VGM Score of B. Additionally, the company could be a top pick for growth investors. HALO has a Growth Style Score of B, forecasting year-over-year ...
Halozyme Therapeutics (NASDAQ:HALO – Get Free Report) is expected to be announcing its earnings results after the market closes on Tuesday, February 18th. Analysts expect the company to announce ...
NASDAQ HALO opened at $58.29 on Friday ... The company has a debt-to-equity ratio of 3.32, a current ratio of 10.36 and a quick ratio of 9.15. The business’s 50-day simple moving average ...
Shares of AI-driven voice recognition expert SoundHound AI (NASDAQ:SOUN) were crushed after Nvidia (NASDAQ:NVDA) revealed it ...
S&P 500 E-Mini futures (ESH25) are up +0.28%, andMarch Nasdaq 100 E-Mini futures (NQH25) are up +0.36% this morning, with ...
TEL AVIV - ParaZero Technologies Ltd. (NASDAQ: PRZO), an aerospace company specializing in safety systems for commercial unmanned aircraft and defense Counter UAS systems, has announced the sale of ...
President of NYU College Republicans resigns after calling Barron Trump ‘an oddity’ ...